Posted in Market Access Multiple myeloma drug Blenrep backed for wider NHS use April 17, 2026 Pharmaphorum The revitalisation of GSK’s Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely. Market AccessOncologyRead full story